MayTech Global Investments’s BeOne Medicines Ltd ONC Stock Holding History

MayTech Global Investments’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-500	Closed	-$62K	–	53
2019 Q2	$62K	Hold	500	–	–	0.03%	31
2019 Q1	$66K	Hold	500	–	–	0.03%	29
2018 Q4	$70K	Hold	500	–	–	0.05%	28
2018 Q3	$86K	Buy	500 +200	+67%	+$33.6K	0.04%	29
2018 Q2	$46K	Hold	300	–	–	0.03%	31
2018 Q1	$50K	Buy	+300	New	+$40.6K	0.03%	34

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

MayTech Global Investments's ONC Position: Q3 2019 in Review

MayTech Global Investments sold out of BeOne Medicines Ltd (ONC) in Q3 2019, closing a stake of 500 shares — an estimated $62K sold.

MayTech Global Investments first reported a position in ONC in Q1 2018 and held it in 6 quarters. The position peaked at $86K in Q3 2018. 196 funds tracked by Wall St. Rank hold ONC as of Q3 2019.

MayTech Global Investments reported no remaining BeOne Medicines Ltd position as of Q3 2019 after selling out during the quarter.
MayTech Global Investments sold 500 BeOne Medicines Ltd shares in Q3 2019, an estimated $62K.
MayTech Global Investments first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 6 quarters.
MayTech Global Investments's BeOne Medicines Ltd position peaked at $86K in Q3 2018.
196 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2019.

Based on MayTech Global Investments's 13F filing for Q3 2019, filed 14 Nov 2019.